DCC4330 |
Py-itc |
Novel suppressor of cancerous cell growth and proliferation |
|
DCC4331 |
Pyochelin |
Bacterial siderophore, acting as an iron-chelating growth promoter for Pseudomonas aeruginosa |
|
DCC4332 |
pyranoxanthone 1 |
Novel inhibitor of p53-MDM2 interaction |
|
DCC4333 |
Pyrd-in-14 |
Novel inhibitor of the PyrD protein (a dihydroorotate dehydrogenase (DHODase) involved in pyrimidine biosynthesis), suppressing bacterial cytotoxicity, biofilm formation and antibiotic resistance |
|
DCC4334 |
Pyrenocine A |
Natural phytotoxin, inducing monopolar spindle formation and suppressing proliferation of cancer cells |
|
DCC4335 |
Pyridinone-14 |
Novel highly potent agonist of the apelin receptor (APJ) receptor (APJ cAMP EC50: human 0.023nM; rat 0.024nM; dog 0.030nM; monkey 0.080nM) |
|
DCC4336 |
Pyrithione Zinc |
Novel KMD5A inhibitor |
|
DCC4337 |
Pysoca Substrate-1 |
Novel BBB-permeable substrate of pyrilamine-sensitive proton-coupled organic cation antiporter (PYSOCA), acting as a selective class I HDAC inhibitor |
|
DCC4338 |
Pyy3-36 |
Y2/Y5 Neuropeptide Y receptor agonist, reducing food intake in normal-weight and obese individuals and the plasma levels of the hunger-promoting hormone ghrelin |
|
DCC4339 |
Pz-1444 |
Novel inverse agonist of 5-HT6 receptor |
|
DCC4340 |
Q8pnap |
Novel class of bright near infrared window II (NIR-II, 1,000 - 1,700 nm) probe, being successfully used to achieve high spatial and temporal resolution imaging of hind limb vasculature, lymphatic system, and small tumor metastasis, as well as precise NIR- |
|
DCC4341 |
q94 Hydrochloride |
Selective PAR1 negative allosteric modulator |
|
DCC4342 |
Qc-308 Hydrochloride |
Novel Heme Oxygenase-1 Inhibitor (HO-1 IC 50 =0.27μM; HO-2 IC 50 =0.46μM) |
|
DCC4343 |
Qd394-me |
Novel reactive oxygen species (ROS) inducer, showing significant cytotoxicity in pancreatic cancer cells |
|
DCC4344 |
Qls-81 |
Novel Nav1.7 channel blocker (IC 50 at 3.5±1.5 μM). being efficacious on chronic pain in mice |
|
DCC4345 |
Qndesa |
Novel fluorescent molecular rotor for the selective detection of the hybrid-conformation 22AG G-Quadruplex |
|
DCC4346 |
Qs Inhibitor 1 |
Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
|
DCC4347 |
Qs Inhibitor 2 |
Novel potent inhibitor of quorum sensing (QS) pathways, strongly blocking agr-type QS in S. aureus |
|
DCC4348 |
Qtc-4-meobne |
Novel multitarget anti-AD agent, significantly increasing in adult neurogenesis and remyelination through Prox1/NeuroD1 and Wnt/β-catenin pathways, demonstrating beneficial effects in preclinical models of AD |
|
DCC4349 |
Quatcy-i2 |
Novel photodynamic antitumor agent |
|
DCC4350 |
Quazepam |
Modulator of specific GABAA receptors via the benzodiazepine site on the GABAA receptor |
|
DCC4351 |
Quilseconazole Besylate |
Potent, orally active fungal Cyp51 (lanosterol 14-α-demethylase) inhibitor |
|
DCC4352 |
Quinine Sulfate |
Natural disrupter of DNA replication and transcription via DNA intercalation, reducing oxygen intake and carbohydrate metabolism and the excitability of muscle fibers, inhibiting the drug efflux pump P-glycoprotein |
|
DCC4353 |
Quoromycin |
Novel antivirulence agent against Vibrio vulnificus, inhibiting the quorum-sensing signaling pathway by controlling the DNA-binding affinity of SmcR and thus effectively alleviating the virulence of V. vulnificus in vitro and in vivo |
|
DCC4354 |
Qw-296 |
Novel microtubule destabilizer |
|
DCC4355 |
R-(+)-eu-1180-453 |
Second-Generation GluN2C- and GluN2D-selective positive allosteric modulator (PAM) of the N-methyl-d-aspartate (NMDA) receptor |
|
DCC4356 |
R(ccug) Ligand 63 |
Novel Potent and Specific Ligand of r(CCUG)exp, Targeting r(CCUG) Repeats in Myotonic Dystrophy Type 2, Facilitating Degradation by RNA Quality Control Pathways |
|
DCC4357 |
r-138329 |
Novel scavenger receptor class B type I blocker |
|
DCC4358 |
r-154716 |
Novel inhibitor of HDL uptake induced by overexpression of scavenger receptor BI (SR-BI) |
|
DCC4359 |
R523062 |
Novel Antiviral agent for Enterovirus D68 |
|